Jaffetilchin Investment Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$154K Buy
2025
Q1
Sell
2024
Q4
$147K Buy